
Knee OA: Naproxcinod performs comparably to naproxen

Knee OA: Naproxcinod performs comparably to naproxen
Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study
Semin Arthritis Rheum. 2011 Feb;40(4):285-97Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
1020 patients with knee osteoarthritis were randomized in order to evaluate the efficacy and safety of naproxcinod treatments compared with placebo and conventional nonsteroidal anti-inflammatory drugs (naproxen 500mg). The study primarily assessed patients for efficacy using the WOMAC pain and function subscales along with several long-term secondary measures (including blood pressure,safety and ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.